Skip to content

Clinical trials

Phase 1/2 Mesothelioma trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma Phase: Phase 1/2 Country / region: United Kingdom Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20161
20171
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Epizyme, Inc.1
NHS Greater Glasgow and Clyde1
RS Oncology LLC1
Virttu Biologics Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma4
Mesothelioma, Malignant2
Carcinoma, Non-Small-Cell Lung1
Lymphoma, Follicular1
Lymphoma, Large B-Cell, Diffuse1
Lymphoma, Non-Hodgkin1
Pancreatic Neoplasms1
Pleural Effusion, Malignant1
Sarcoma, Synovial1

Trials

Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.